Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Petanceska, S. DeRosa, Vicki Olm, Nichole Diaz, Ali Sharma, T. Thomas-Bryant, K. Duff, M. Pappolla, L. Refolo (2002)
Statin therapy for Alzheimer's disease: will it work?Journal of molecular neuroscience : MN, 19 1-2
Pengxiang Li, Michelle Kim, J. Doshi (2010)
Comparison of the performance of the CMS Hierarchical Condition Category (CMS-HCC) risk adjuster with the charlson and elixhauser comorbidity measures in predicting mortalityBMC Health Services Research, 10
B. McGuinness, P. Passmore (2010)
Can statins prevent or help treat Alzheimer's disease?Journal of Alzheimer's disease : JAD, 20 3
B. McGuinness, D. Craig, R. Bullock, P. Passmore (2016)
Statins for the prevention of dementia.The Cochrane database of systematic reviews, 1
B. Reed, S. Villeneuve, W. Mack, C. DeCarli, H. Chui, W. Jagust (2014)
Associations between serum cholesterol levels and cerebral amyloidosis.JAMA neurology, 71 2
A. Koudinov, T. Berezov, N. Koudinova (2002)
Cholesterol and Alzheimer's disease: is there a link?Neurology, 58 7
S. Petanceska, S. DeRosa, Ali Sharma, Nichole Diaz, K. Duff, S. Tint, L. Refolo, M. Pappolla (2007)
Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterolJournal of Molecular Neuroscience, 20
P. Zandi, D. Sparks, A. Khachaturian, J. Tschanz, M. Norton, Martin Steinberg, K. Welsh-Bohmer, J. Breitner (2005)
Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.Archives of general psychiatry, 62 2
Q. Gu, R. Paulose‐Ram, V. Burt, Brian Kit (2014)
Prescription cholesterol-lowering medication use in adults aged 40 and over: United States, 2003-2012.NCHS data brief, 177
Nina Shepardson, G. Shankar, D. Selkoe (2011)
Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations.Archives of neurology, 68 11
Nina Shepardson, G. Shankar, D. Selkoe (2011)
Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies.Archives of neurology, 68 10
C. Schweiger (2001)
[Statins and the risk of dementia].Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2 3
F. Lin, Yun-Shiuan Chuang, H. Hsieh, Tzu-Chi Lee, Kuei-Fen Chiu, Ching-Kuan Liu, Ming-Tsang Wu (2015)
Early Statin Use and the Progression of Alzheimer DiseaseMedicine, 94
H. Hendrie, A. Hake, K. Lane, C. Purnell, F. Unverzagt, V. Smith‐Gamble, J. Murrell, A. Ogunniyi, O. Baiyewu, Christopher Callahan, A. Saykin, Stanley Taylor, K. Hall, S. Gao (2015)
Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans.Ethnicity & disease, 25 3
M. Haag, A. Hofman, P. Koudstaal, B. Stricker, M. Breteler (2008)
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam StudyJournal of Neurology, Neurosurgery, and Psychiatry, 80
S. Vuletic, Robert Riekse, S. Marcovina, E. Peskind, W. Hazzard, J. Albers (2006)
Statins of Different Brain Penetrability Differentially Affect CSF PLTP ActivityDementia and Geriatric Cognitive Disorders, 22
L. Warnich, B. Drögemöller, M. Pepper, C. Dandara, Galen Wright (2011)
Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow NationCurrent Pharmacogenomics and Personalized Medicine, 9
Haijian Wang, K. Ding, Yang Zhang, Li Jin, I. Kullo, F. He (2007)
Comparative and evolutionary pharmacogenetics of ABCB1: complex signatures of positive selection on coding and regulatory regionsPharmacogenetics and Genomics, 17
LM Mangravite, C Thorn, R. Krauss (2006)
Clinical implications of pharmacogenomics of statin treatmentThe Pharmacogenomics Journal, 6
N. Kandiah, H. Feldman (2009)
Therapeutic potential of statins in Alzheimer's diseaseJournal of the Neurological Sciences, 283
M. Simons, P. Keller, J. Dichgans, J. Schulz (2001)
Cholesterol and Alzheimer’s diseaseNeurology, 57
M. Sano, K. Bell, D. Galasko, J. Galvin, R. Thomas, C. Dyck, P. Aisen (2011)
A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer diseaseNeurology, 77
M. Blackwell, S. Iacus, Gary King, G. Porro (2009)
Cem: Coarsened Exact Matching in StataThe Stata Journal, 9
K. Fung, James Pan, S. Ohnuma, P. Lund, Jessica Pixley, C. Kimchi-Sarfaty, S. Ambudkar, M. Gottesman (2014)
MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer.Cancer research, 74 2
J. Jukema, C. Cannon, A. Craen, R. Westendorp, S. Trompet (2012)
The controversies of statin therapy: weighing the evidence.Journal of the American College of Cardiology, 60 10
G. Lesser, M. Beeri, J. Schmeidler, D. Purohit, V. Haroutunian (2011)
Cholesterol and LDL relate to neuritic plaques and to APOE4 presence but not to neurofibrillary tangles.Current Alzheimer research, 8 3
Julie Zissimopoulos, E. Crimmins, Patricia St.Clair (2014)
The Value of Delaying Alzheimer’s Disease OnsetForum for Health Economics and Policy, 18
P. Chong, P. Chong, J. Seeger, C. Franklin (2001)
Clinically relevant differences between the statins: implications for therapeutic selection.The American journal of medicine, 111 5
L. Refolo, M. Pappolla, J. Lafrancois, B. Malester, S. Schmidt, T. Thomas-Bryant, G. Tint, Rong Wang, M. Mercken, S. Petanceska, K. Duff (2001)
A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's DiseaseNeurobiology of Disease, 8
Marisa Schoen, K. Richardson, B. French, Matthew Mitchell, S. Arnold, P. Heidenreich, D. Rader, C. Umscheid, Emil Degoma (2014)
Statins and Cognitive Function: A Systematic Review†∗Journal of Clinical Lipidology, 8
J. Caballero, M. Nahata (2004)
Do statins slow down Alzheimer's disease? A reviewJournal of Clinical Pharmacy and Therapeutics, 29
M. Perrin, M. Perrin, M. Terry, K. Kleinhaus, L. Deutsch, R. Yanetz, E. Tiram, R. Calderon, Yechiel Friedlander, Ora Paltiel, S. Harlap, S. Harlap (2007)
Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort studyBMC Medicine, 5
Ge Li, J. Shofer, I. Rhew, W. Kukull, E. Peskind, W. McCormick, J. Bowen, G. Schellenberg, P. Crane, J. Breitner, E. Larson (2010)
Age‐Varying Association Between Statin Use and Incident Alzheimer's DiseaseJournal of the American Geriatrics Society, 58
M. Tang, P. Cross, Howard Andrews, D. Jacobs, S. Small, K. Bell, C. Merchant, R. Lantigua, R. Costa, Y. Stern, R. Mayeux (2001)
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern ManhattanNeurology, 56
Key PointsQuestionWhat is the association between statin use and the incidence of Alzheimer disease among male and female Medicare beneficiaries? FindingsIn this study, high vs low exposure to statins was associated with a lower incidence of Alzheimer disease for women and men, respectively. The reduction in incidence of Alzheimer disease varied across race/ethnicity and type of statin. MeaningStatins may potentially affect Alzheimer disease risk, so physicians should consider which statin is prescribed to their patients.
JAMA Neurology – American Medical Association
Published: Feb 12, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.